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ABSTRACT
Fibroids are the most common benign tumors affecting fertility and quality of life. Different methods either definitive or fertility sparing 
are used for their management by using open, laparoscopic and robotic techniques. This is a narrative review presenting the role and the 
advantages of robotic surgery in fibroids (myomectomies or hysterectomies). Such a management is effective, safe and feasible in hands  
of well-trained teams even for multiple, large or deep located fibroids.
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INTRODUCTION
Fibroids are the most common benign uterine tumors deriv-
ing from the smooth muscle cells of the myometrium. They 
can cause uterine bleeding, pain, pressure symptoms and 
infertility (1). Depending on their anatomic location they 
are characterised as subserosal, intramural, submucosal 
and pedunculated fibroids. Ultrasound is the most widely 
used modality for fibroids diagnosis due to its availability 
and cost-effectiveness. Magnetic resonance imaging (MRI) 
is the best modality for visualizing the size and location of 
all uterine myomas and rule out adenomyosis. However, 
due to the expense of MRI, its use is best reserved for sur-
gical planning for complicated procedures (2). Initially, ex-
pectant management could be a reasonable option for some 
women with fibroids or, “empirically”, fibroids are treated 
conservatively either with progestin-only treatments or 
combined hormonal contraceptives or GnRH analogues (3). 
However, they are the primary indication of hysterectomies 
in order to have a definitive treatment. Their management 
could also be fertility sparing if that is possible by perform-
ing myomectomy or uterine embolization (1). Laparoscopic 
or open techniques, depending on each surgeon’s prefer-
ence and experience, are offered as treatment options while 
recently robotic procedures are also suggested.
The da Vinci© surgical system (Intuitive Surgical, 
Sunnyvale, California) received FDA approval in 2005. 
Robotic procedures have been introduced in order to im-
prove surgical performance. Increased dexterity, greater 
range of motion and better depth perception are the main 
advantages of robotic-assisted techniques. Its limitations 
include lack of tactile feedback and increased cost. Robot-
ic procedures combine the advantages of open and lapa-
roscopic procedures and are another alternative in the 
management of fibroids either with myomectomy or with 
hysterectomy (4).
The aim of this narrative review is to present the use, 
the criteria and the advantages of robotic surgery in the 
treatment of fibroids.
DISCUSSION
Different techniques including open, laparoscopic or ro-
botic procedures are “concurrently” used in the manage-
ment of fibroids and robotic-assisted procedures are be-
coming more common (4). The patient is preoperatively 
assessed with imaging scans including ultrasound and 
MRI and she signs the informed consent when she is in-
formed about the type of planned procedure and possible 
risks of it including infection, bleeding and injury of ad-
jacent organs. “A little arbitrarily”, candidates for robotic 
myomectomy are all the patients with any single myoma 
<15 cm or with <15 myomas in total while palpation of the 
uterine fundus above the umbilicus, with diffuse adeno-
myosis or a uterine cavity which cannot be clearly visu-
alized by imaging techniques are contraindications of ro-
botic myomectomy (5). In these cases, a total or subtotal 
hysterectomy could be performed.
Patient is operated in dorsal lithotomy position in  Allen 
stirrups with the arms padded and tucked. After trocar 
placement, the patient would lie in Trendelenburg posi-
tion. The assistant’s laparoscopic port is used for suction/
irrigation, passage of needles, tissue retraction, and mor-
cellation. The most commonly used robotic instruments 
are Cadiere or Maryland bipolar forceps, harmonic shears, 
and mega or large needle driver. Initially, the fibroid lo-
cation is exactly determined and then vasopressin is in-
jected into the myometrium surrounding the fibroid. An 
incision is performed over the fibroid in a longitudinal or 
horizontal axis followed by enucleation of it by using a ro-
botic tenaculum and/or a bipolar coagulator in addition to 
the harmonic shears. The assistant could also help by addi-
tional traction with a laparoscopic tenaculum. Multilayer 
closure employing barbed sutures is usually performed. 
The specimen is morcelated by taking care of the adjacent 
tissues especially the bowel and the specimen is retrieved 
through the assistant’s port.
Regarding the surgical steps of a robotic hysterecto-
my, two Vicryl© sutures are put on the cervix and then the 
uterus is instrumented with manipulator and a cervical 
cap is tied with the sutures. An indwelling foley catheter 
is also used at outset. Then, uncomplicated Veress needle 
is fitted and pneumoperitoneum and trocars insertion are 
performed followed by side docking and instrumentation. 
Usually, the bipolar diathermy (DT) is set at 40 and the 
scissors are put through the right main port with monop-
olar DT at 40 cut and coagulation. Cadiere or Maryland 
forceps are placed in the third arm. Then, after incising 
with monopolar DT, the broad ligaments are entered and 
the ureters are identified bilaterally. The infundibulopelvic 
pedicles and round ligaments are “taken” with bipolar and/
or monopolar DT. The uterovesical fold is taken with mo-
nopolar DT and reflection of the bladder follows. The uter-
ine vessels are then skeletalised and taken with bipolar and 
monopolar DT. The vagina is entered anteriorly on top of 
the manipulator’s cervical cap and the dissection is con-
tinued circumferentially using monopolar DT. The uterine 
specimen could be extracted through the vagina, through 
a  mini-laparotomy or morcellated depending on its di-
mensions and suspicion for malignancy. The vaginal vault 
is then closed with continuous barbed suture. Regarding 
the postoperative care, the patients are early mobilised and 
usually are discharged the first postoperative day. In future 
pregnancies, the risk of uterine rupture is very low when 
the myometrium is appropriately repaired (6).
Robotic system preserves the advantages of conven-
tional laparoscopy while it offers the possibility to the gy-
naecologist to operate with more dexterity on the uterus, 
especially when performing a myomectomy. The articulat-
ed instruments permit a wide range of motions while they 
increase the ability of the surgeon to work efficiently. The 
3-dimention stereoscopic vision by the use of binocular 
optics, the filtration of the tremor and the less operator 
fatigue are some of the obvious advantages of such opera-
tions. It is suggested that a diagnostic laparoscopy should 
be used in order to clarify the exact positions of the tro-
cars in order to have uncomplicated access to the pelvis. 
Robotic procedures can be safely performed after taking 
into account the physiological changes of pneumoperito-
neum and steep Trendelenburg position during a preop-
erative anaesthetic review (7). The CO2 pressure required 
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for exposure is often lower in correlation with traditional 
laparoscopy as result of the mechanical lift of the robot 
(8). All the above mentioned advantages can lead to more 
anatomical procedures.
A recent meta-analysis revealed that robotic procedures 
have significant short term benefits compared to open sur-
gery but the results were found to be similar to laparoscop-
ic procedures (9). It was shown that there is no significant 
difference in number and weight of fibroids or operating 
times when comparing robotic with laparoscopic or open 
myomectomy (10, 11). However, blood loss is less in the ro-
botic group (10). When comparing robotic with open myo-
mectomies, although the operative time is double (261 ver-
sus 125 minutes), the hospital stay was half the days in the 
robotic cases (1.5 versus 2.7 days) (12). In all those studies, 
the rates of conversion to open surgery and blood transfu-
sion are minimal. The most common reason of conversion 
is the location or the volume of the fibroid and/or the luck 
of experience of the surgeon. Regarding the pregnancy out-
comes after robotic myomectomies, a cohort study revealed 
that the mean time to conception was 12.9 ± 11.5 months, 
spontaneous abortions occurred in 18.9%, while preterm 
delivery in 17.4% of the achieved pregnancies. The uterine 
rupture rates were 1.1% (13). Another study showed that 
the pregnancy rate is 69% and the natural conception rate 
55% after robotic myomectomies (14). Additionally, preop-
erative obesity is not a contraindication or risk factor of 
poor outcome for women undergoing robotic myomecto-
my (15). So, the robotic assisted surgery also permits the 
realization of a key hole operation (at most 10 to 12 mm) (8) 
which can be interpreted into significantly less blood loss, 
less pain, shorter recovery time as well as shorter hospital 
stay, quicker return to normal activity and better aesthetic 
result. Moreover, the learning curve of such operations is 
rapid compared to laparoscopy, while at the same time the 
good clinical outcomes are equally effective as conventional 
laparoscopy and within similar operating times.
On the other hand, the most significant disadvantages 
include the high costs of use, the bulky machinery and the 
need for staff training. Regarding the cost, it was shown 
that open myomectomy costs $4,937 compared to laparos-
copy which costs $6,219 and robotic procedures $7,299 (16). 
Of course, entry of new robotic systems in the market as 
well as use of the robot by different surgical teams and in 
a high volume of patients could decrease the cost disad-
vantage. Moreover, some authors argue that robotic are 
longer operations and the loss of tactile sensation makes 
difficult the sensation of an intramural fibroid (17).
We present a state of the art narrative review dealing 
with management of uterine fibroids, especially the surgi-
cal treatment using the da Vinci© robotic system. We brief-
ly describe the fertility sparing procedure – myomectomy 
– and the definitive procedure – hysterectomy – pointing 
out the advantages of the robotic surgery (increased dex-
terity, maneuverability of the system, greater range of 
motion and better depth perception) and compare the ro-
botic, laparoscopic and open surgery in terms of complica-
tion rate, operative time, hospital stay, blood loss, learning 
curve and cost.
The review mentioned both approaches conservative 
and definitive with bigger focus on conservative approach. 
We include a comparison of the laparotomic versus laparo-
scopic versus robotic assisted surgery. Recent meta-analy-
ses and prospective studies are favouring the later two for 
shorter hospital stay and less blood loss (18–20). We would 
also like to note that morcelation of the tissue of fibroid af-
ter myomectomy – especially use of power morcellation – 
could rise a controversy according to FDA advise (21, 22). 
For this reason, we suggest that any type of morcellation 
should be performed inside a laparoscopic bag to avoid tis-
sue contamination (22).
Robotic system in conservative management is a very 
interesting modality, though it struggles in comparison 
with laparoscopic management because it brings hard-
ly any advantage for its higher cost. There are still lot of 
countries where the myomectomy with robotic system is 
still not covered by insurance companies and the spend-
ing power of patients is still very low and this modality is 
therefore unavailable. But this is the controversy worth to 
mention. When the cost issue is going to get overcome that 
could be the time when robotic modality in conservative 
management of fibroids would become more common in 
the future.
CONCLUSION
In conclusion, robotic myomectomy or hysterectomy is 
an equally effective, feasible and safe alternative in well-
trained hands compared to the traditional methods of 
open or laparoscopic surgery. The till now evidence shows 
that robotic myomectomy has comparable results to open 
and laparoscopic techniques. More randomized prospec-
tive studies are necessary to clarify the role of robotic 
management especially in the long term outcomes such as 
pregnancy, miscarriage, caesarean section and live birth 
rates.
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